SourcingLink.net Announces Corporate Name Change to Oncology Pharma, Inc.
June 17, 2019 08:30 ET | Oncology Pharma, Inc.
New Name Reflects the Company's Core Business of Oncology Therapeutics SAN FRANCISCO, CA, June 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SourcingLink.net, Inc. has announced that it has...
Veterinary Oncology Licensing Agreement Signed Between SourcingLink.net and NanoSmart Pharmaceuticals, Inc.
April 03, 2019 07:00 ET | SourcingLink.net, Inc.
San Francisco, CA, April 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net, Inc. (SNET), a San Francisco, CA based company, announced today that it entered into an exclusive,...
SourcingLink.net Enters into an Exclusive Worldwide Licensing Agreement with NanoSmart Pharmaceuticals for Anti-Nuclear Antibody (ANA)-Targeted Doxorubicin Formulations to Treat Cancer
March 25, 2019 07:30 ET | SourcingLink.net, Inc.
SAN FRANCISCO, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SourcingLink.net, Inc. (SNET), announced today that it entered into an exclusive worldwide licensing agreement with NanoSmart...
SourcingLink.net Signs a Letter of Intent with NanoSmart Pharmaceuticals, Inc. for a Licensee and Co-Development Collaboration of NanoSmart's Proprietary Targeted Drug Delivery System for Cancer Drugs
February 26, 2019 16:00 ET | SourcingLink.net, Inc.
San Francisco, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET), an early stage oncology company, is a pioneering company based in San Francisco,...
SourcingLink.net to Investigate the Potential of Combining its Novel Autologous Immune-Therapy with Synergistic Oncology Therapies
February 12, 2019 16:00 ET | SourcingLink.net, Inc.
San Francisco, CA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET), based in San Francisco, is a pioneering biotech company focused on oncology .  The company...
SourcingLink.net to Leverage Pharmacogenomics in Its Oncology Therapy Development and Clinical Trial Program
February 05, 2019 08:30 ET | SourcingLink.net, Inc.
San Francisco, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET) is announcing that it will harness the power of pharmacogenomics in its oncology therapy...
SourcingLink.net Plans to Use 'Game Changing' Diagnostic Tool in its R&D and Beyond
January 28, 2019 21:31 ET | SourcingLink.net, Inc.
San Francisco, CA, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET) is pleased to announce that it is excited about integrating liquid biopsy in its R&D...
SourcingLink.net Licenses an Immune-Cell Therapy in Oncology from Tulynode Biosciences, Inc.
January 22, 2019 21:57 ET | SourcingLink.net, Inc.
San Francisco, CA, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SourcingLink.net (OTC PINK: SNET) has entered into a licensing agreement with Tulynode Biosciences, Inc. of San Diego, CA. ...
SourcingLink.net (SNET) Update on the Lac Fire Lithium Property and Completion of 43-101 Compliant Report with Recommended Work Program
March 29, 2018 11:23 ET | SourcingLink.net, Inc.
SAN DIEGO, CA, March 29, 2018 (GLOBE NEWSWIRE) -- SourcingLink.net Inc. (OTC Pink: SNET) is pleased to announce the renewal of the Lac Fire Claims, completion of a 43-101 compliant report on the...
SourcingLink.net Locates High Grade Lithium Mineralization during the Phase I Exploration Program on the Lac Fire Lithium Property
January 25, 2018 08:00 ET | SourcingLink.net, Inc.
SAN DIEGO, CA, Jan. 25, 2018 (GLOBE NEWSWIRE) -- SourcingLink.net Inc. (OTC Pink: SNET) is pleased to announce the completion of Phase I surface exploration on the Lac Fire Lithium property in James...